Abstract:We report three critically ill pediatric patients (aged 6–10 years), presenting with features of multisystem inflammatory syndrome in children (MIS-C) from April 4 to May 10, 2020, to a tertiary-care center in New Jersey, United States. All patients tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and were previously healthy. Clinical presentations were similar with fever, abdominal pain, gastrointestinal complaints, and/or rash. One patient had altered mental status w… Show more
“…Predominant symptoms of stomach and prevalence of cholestasis than the liver injury hypothetically caused by the higher expression of angiotensin-converting enzyme-2 receptors in the gastrointestinal epithelium cells and cholangiocytes than in hepatocytes [ 9 ]. Our patients had circulatory shock requiring subsequence inotropic support, similar to the study of MIS-C by Kest et al in New Jersey, United States of America/USA [ 10 ].…”
Section: Discussionsupporting
confidence: 72%
“…Feldstein et al reported their study of MIS-C in the United States, there is only 70 % that PCR was positive [ 8 ]. Leukocytosis was found, this is following the research by Kest et al, which in his research all patients with MIS-C was leukocytosis [ 10 ]. Our case had severe anemia and leukocytosis, but lymphocytopenia was not found.…”
Highlights
The multiple inflammatory syndrome in children (MIS-C) is a severe complication from COVID-19 in children and adolescents.
The clinical pictures of MIS-C were hyperinflammatory, which causing the failure of multi-organs and shock.
We report the case of MIS-C concurrent with unusual dengue infection leading to a fatal case.
“…Predominant symptoms of stomach and prevalence of cholestasis than the liver injury hypothetically caused by the higher expression of angiotensin-converting enzyme-2 receptors in the gastrointestinal epithelium cells and cholangiocytes than in hepatocytes [ 9 ]. Our patients had circulatory shock requiring subsequence inotropic support, similar to the study of MIS-C by Kest et al in New Jersey, United States of America/USA [ 10 ].…”
Section: Discussionsupporting
confidence: 72%
“…Feldstein et al reported their study of MIS-C in the United States, there is only 70 % that PCR was positive [ 8 ]. Leukocytosis was found, this is following the research by Kest et al, which in his research all patients with MIS-C was leukocytosis [ 10 ]. Our case had severe anemia and leukocytosis, but lymphocytopenia was not found.…”
Highlights
The multiple inflammatory syndrome in children (MIS-C) is a severe complication from COVID-19 in children and adolescents.
The clinical pictures of MIS-C were hyperinflammatory, which causing the failure of multi-organs and shock.
We report the case of MIS-C concurrent with unusual dengue infection leading to a fatal case.
“…CSF pleocytosis may be indicative of infection, inflammation or other CNS injury [ 247 ]. There were 29/409 patients (7%) who had a CSF WBC count of 21–100 cells/μL, all of whom had symptoms that localized to the CNS; 10 (34%) of these patients had CSF RBC counts provided, all of whom had a CSF RBC count of <300 cells/μL; Naz et al described a patient with headache and indicated that CSF was consistent with viral meningitis, but the CSF WBC count was unclear, as it was noted that he had 90 lymphocytes and 10 neutrophils (no units provided so we were unsure if these were percentages or numbers of cells), so we classified these findings as “increased WBC.” [ 10 , [27] , [28] , [29] , 44 , 75 , 79 , [127] , [128] , [129] , 140 , 145 , 154 , 160 , 161 , 170 , 173 , 183 , 184 , 187 , 198 , 205 , 208 , 216 ] …”
We sought to review the literature on cerebrospinal fluid (CSF) testing in patients with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2. Methods: We performed a systematic review of Medline and Embase between December 1, 2019 and November 18, 2020 to identify case reports or series of patients who had COVID-19 diagnosed based on positive SARS-CoV-2 polymerase chain reaction (PCR) or serologic testing and had CSF testing due to a neurologic symptom. Results: We identified 242 relevant documents which included 430 patients with COVID-19 who had acute neurological symptoms prompting CSF testing. Of those, 321 (75%) patients had symptoms that localized to the central nervous system (CNS). Of 304 patients whose CSF was tested for SARS-CoV-2 PCR, there were 17 (6%) whose test was positive, all of whom had symptoms that localized to the central nervous system (CNS). The majority (13/17, 76%) of these patients were admitted to the hospital because of neurological symptoms. Of 58 patients whose CSF was tested for SARS-CoV-2 antibody, 7 (12%) had positive antibodies with evidence of intrathecal synthesis, all of whom had symptoms that localized to the CNS. Of 132 patients who had oligoclonal bands evaluated, 3 (2%) had evidence of intrathecal antibody synthesis. Of 77 patients tested for autoimmune antibodies in the CSF, 4 (5%) had positive findings. Conclusion: Detection of SARS-CoV-2 in CSF via PCR or evaluation for intrathecal antibody synthesis appears to be rare. Most neurological complications associated with SARS-CoV-2 are unlikely to be related to direct viral neuroinvasion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.